Shared on05 Sep 25
Despite Voya Financial's Q2 earnings beat, robust free cash flow, and positive outlook for Health Solutions and Wealth segments, analysts maintained the price target at $83.27, reflecting confidence in its capital-light model amid industry strength. Analyst Commentary Q2 earnings beat expectations, driven by favorable prior year development in stop-loss and selective underwriting.
Shared on30 Apr 25Fair value Decreased 0.26%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Decreased 1.74%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 6.12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.61%
AnalystConsensusTarget has increased revenue growth from 0.4% to 0.5%.
Shared on02 Apr 25Fair value Decreased 2.62%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Increased 0.049%
AnalystConsensusTarget has decreased revenue growth from 1.1% to 0.4%.